Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Apr 29, 2013

5229_dirs_2013-04-29_2d461bbc-cdad-44b4-8e3c-62bed595e39e.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4940D

AstraZeneca PLC

29 April 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rules DTR 3.1.4R

We hereby inform you that the interest of Simon Lowth, a Director of the Company, in the ordinary shares of AstraZeneca PLC has changed as detailed below.

On 26 April 2013, Mr Lowth exercised an option over 65,131 AstraZeneca ordinary shares at an option price of 2280 pence per share. Immediately following the exercise, Mr Lowth sold 54,561 of the 65,131 shares so acquired at a price of 3316 pence per share to cover the cost of exercise and associated taxes. He retained the balance of 10,570 shares.

On 29 April 2013, Mr Lowth sold 8,690 AstraZeneca ordinary shares at a price of 3328 pence per share for reasons of personal financial planning.

As a result of these transactions, Mr Lowth has an interest in 299,931 shares, which represent approximately 0.02% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

29 April 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUKAOROOASUAR